{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:51:26Z","timestamp":1793641886341,"version":"4.5.1"},"reference-count":41,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autoimmune liver diseases (AILDs) are life-threatening chronic liver diseases, mainly including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and AIH\u2013PBC overlap syndrome (OS), which are difficult to distinguish clinically at early stages. This study aimed to establish model to achieve the purpose of the diagnosis of AIH\/PBC OS in a noninvasive way. A total of 201 AILDs patients were included in this retrospective study who underwent liver biopsy during January 2011 to December 2020. Serological factors significantly associated with OS were determined by the univariate analysis. Two multivariate models based on these factors were constructed to predict the diagnosis of AIH\/PBC OS using logistic regression and random forest analysis. The results showed that immunoglobulins G and M had significant importance in both models. In logistic regression model, anti-Sp100, anti-Ro-52, anti-SSA, or antinuclear antibody positivity were risk factors for OS. In random forest model, activated partial thromboplastin time and \u0251-fetoprotein level were important. To distinguish PBC and OS, the sensitivity and specificity of logistic regression model were 0.889 and 0.727, respectively, and the sensitivity and specificity of random forest model were 0.944 and 0.818, respectively. In conclusion, we established two predictive models for the diagnosis of AIH\/PBC OS in a noninvasive method and they showed better performance than Paris criteria for the definition of AIH\/PBC OS.<\/jats:p>","DOI":"10.1515\/med-2022-0526","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T04:05:46Z","timestamp":1664337946000},"page":"1550-1558","source":"Crossref","is-referenced-by-count":12,"title":["Noninvasive diagnosis of AIH\/PBC overlap syndrome based on prediction models"],"prefix":"10.1515","volume":"17","author":[{"given":"Kailing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University , Changsha , Hunan 410008 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University , Changsha , Hunan 410008 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University , Changsha , Hunan 410008 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University , Changsha , Hunan 410008 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University , Changsha , Hunan 410008 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University , Changsha , Hunan 410008 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University , Changsha , Hunan 410008 , China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University , Changsha , Hunan 410007 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"2022120618373723687_j_med-2022-0526_ref_001","doi-asserted-by":"crossref","unstructured":"Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006 Jan 5;354(1):54\u201366.","DOI":"10.1056\/NEJMra050408"},{"key":"2022120618373723687_j_med-2022-0526_ref_002","doi-asserted-by":"crossref","unstructured":"Purohit T, Cappell MS. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol. 2015;7(7):926\u201341.","DOI":"10.4254\/wjh.v7.i7.926"},{"key":"2022120618373723687_j_med-2022-0526_ref_003","doi-asserted-by":"crossref","unstructured":"Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014;60(1):210\u201323.","DOI":"10.1016\/j.jhep.2013.09.020"},{"key":"2022120618373723687_j_med-2022-0526_ref_004","doi-asserted-by":"crossref","unstructured":"Chazouill\u00e8res O. Overlap syndromes. Dig Dis. 2015;33(2):181\u20137.","DOI":"10.1159\/000440831"},{"key":"2022120618373723687_j_med-2022-0526_ref_005","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL Clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237\u201367.","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"2022120618373723687_j_med-2022-0526_ref_006","doi-asserted-by":"crossref","unstructured":"Chazouill\u00e8res O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology. 1998;28(2):296\u2013301.","DOI":"10.1002\/hep.510280203"},{"key":"2022120618373723687_j_med-2022-0526_ref_007","doi-asserted-by":"crossref","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol. 2011;54(2):374\u201385.","DOI":"10.1016\/j.jhep.2010.09.002"},{"key":"2022120618373723687_j_med-2022-0526_ref_008","doi-asserted-by":"crossref","unstructured":"Pells G, Mells GF, Carbone M, Newton JL, Bathgate AJ, Burroughs AK, et al. The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort. J Hepatol. 2013;59(1):67\u201373.","DOI":"10.1016\/j.jhep.2013.02.019"},{"key":"2022120618373723687_j_med-2022-0526_ref_009","doi-asserted-by":"crossref","unstructured":"Kuiper EM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2010;8(6):530\u20134.","DOI":"10.1016\/j.cgh.2010.03.004"},{"key":"2022120618373723687_j_med-2022-0526_ref_010","doi-asserted-by":"crossref","unstructured":"European association for the study of the liver. EASL clinical practice guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145\u201372.","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"2022120618373723687_j_med-2022-0526_ref_011","doi-asserted-by":"crossref","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. American association for the study of liver diseases. Liver biopsy. Hepatology. 2009;49(3):1017\u201344.","DOI":"10.1002\/hep.22742"},{"key":"2022120618373723687_j_med-2022-0526_ref_012","doi-asserted-by":"crossref","unstructured":"Spengler U, Fischer HP. Die leberbiopsie im schnittpunkt von klinischer und pathologischer Diagnostik [Liver biopsy at the intersection of clinical and pathological diagnosis]. Pathologe. 2008;29(1):6\u201314.","DOI":"10.1007\/s00292-007-0960-4"},{"key":"2022120618373723687_j_med-2022-0526_ref_013","doi-asserted-by":"crossref","unstructured":"Limaye SS, Mastrangelo CM. Systems modeling approach for reducing the risk of healthcare-associated infections. Adv Health Care Manag. 2019;18:35\u201360 10.1108\/S1474-823120190000018013. PMID: 32077650.","DOI":"10.1108\/S1474-823120190000018013"},{"key":"2022120618373723687_j_med-2022-0526_ref_014","doi-asserted-by":"crossref","unstructured":"Ramos-Casals M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado MJ, Khamashta MA; BIOGEAS Study Group. Autoimmune diseases induced by biological agents: A double-edged sword? Autoimmun Rev. 2010;9(3):188\u201393.","DOI":"10.1016\/j.autrev.2009.10.003"},{"key":"2022120618373723687_j_med-2022-0526_ref_015","doi-asserted-by":"crossref","unstructured":"Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis. 2009;68(7):1086\u201393.","DOI":"10.1136\/ard.2008.094474"},{"key":"2022120618373723687_j_med-2022-0526_ref_016","doi-asserted-by":"crossref","unstructured":"Chen W, Bi K, Jiang J, Zhang X, Diao H. Integrated analysis of human influenza A (H1N1) virus infection related genes to construct a suitable diagnostic model. Biocell. 2021;45(4):885\u201399.","DOI":"10.32604\/biocell.2021.012938"},{"key":"2022120618373723687_j_med-2022-0526_ref_017","doi-asserted-by":"crossref","unstructured":"Li J, Li H, Zeng H, Zheng R, Cao M, Sun D, et al. Trends in high-risk rates and screening rates for the population-based cancer screening program on esophageal, stomach and liver cancer in China, 2010-2016. J Natl Cancer Cent. 2021;1(3):101.","DOI":"10.1016\/j.jncc.2021.05.001"},{"key":"2022120618373723687_j_med-2022-0526_ref_018","doi-asserted-by":"crossref","unstructured":"Waljee AK, Lipson R, Wiitala WL, Zhang Y, Liu B, Zhu J, et al. Predicting hospitalization and outpatient corticosteroid use in inflammatory bowel disease patients using machine learning. Inflamm Bowel Dis. 2017;24(1):45\u201353.","DOI":"10.1093\/ibd\/izx007"},{"key":"2022120618373723687_j_med-2022-0526_ref_019","doi-asserted-by":"crossref","unstructured":"Hu X, Jing FY, Wang QJ, Shi LY, Cao YF, Zhu ZT. Alteration of ornithine metabolic pathway in colon cancer and multivariate data modelling for cancer diagnosis. Oncologie. 2021;23(2):203\u201317.","DOI":"10.32604\/Oncologie.2021.016155"},{"key":"2022120618373723687_j_med-2022-0526_ref_020","doi-asserted-by":"crossref","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Par\u00e9s A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169\u201376.","DOI":"10.1002\/hep.22322"},{"key":"2022120618373723687_j_med-2022-0526_ref_021","doi-asserted-by":"crossref","unstructured":"Muratori P, Granito A, Pappas G, Muratori L. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. Hepatology. 2009 May;49(5):1782\u20133.","DOI":"10.1002\/hep.22825"},{"key":"2022120618373723687_j_med-2022-0526_ref_022","doi-asserted-by":"crossref","unstructured":"Candia R, Norero B, Ag\u00fcero C, D\u00edaz L, Ortega JP, Wolff R, et al. Validation of the simplified criteria for the diagnosis of autoimmune hepatitis in chilean-hispanic patients. Ann Hepatol. 2017;16(5):772\u20139.","DOI":"10.5604\/01.3001.0010.2787"},{"key":"2022120618373723687_j_med-2022-0526_ref_023","doi-asserted-by":"crossref","unstructured":"Liu F, Pan ZG, Ye J, Xu D, Guo H, Li GP, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: simplified criteria may be effective in the diagnosis in Chinese patients. J Dig Dis. 2014;15(12):660\u20138.","DOI":"10.1111\/1751-2980.12196"},{"key":"2022120618373723687_j_med-2022-0526_ref_024","doi-asserted-by":"crossref","unstructured":"Shkurin A, Vellido A. Using random forests for assistance in the curation of G-protein coupled receptor databases. Biomed Eng Online. 2017;16:75.","DOI":"10.1186\/s12938-017-0357-4"},{"key":"2022120618373723687_j_med-2022-0526_ref_025","doi-asserted-by":"crossref","unstructured":"Wu J, Qiu J, Xie E, Jiang W, Zhao R, Qiu J, et al. Predicting in-hospital rupture of type A aortic dissection using Random Forest. J Thorac Dis. 2019;11(11):4634\u201346.","DOI":"10.21037\/jtd.2019.10.82"},{"key":"2022120618373723687_j_med-2022-0526_ref_026","doi-asserted-by":"crossref","unstructured":"Su X, Xu Y, Tan Z, Wang X, Yang P, Su Y, et al. Prediction for cardiovascular diseases based on laboratory data: An analysis of random forest model. J Clin Lab Anal. 2020;34(9):e23421.","DOI":"10.1002\/jcla.23421"},{"key":"2022120618373723687_j_med-2022-0526_ref_027","doi-asserted-by":"crossref","unstructured":"Muratori P, Granito A, Pappas G, Pendino GM, Quarneti C, Cicola R, et al. The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol. 2009;104(6):1420\u20135.","DOI":"10.1038\/ajg.2009.126"},{"key":"2022120618373723687_j_med-2022-0526_ref_028","doi-asserted-by":"crossref","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. American association for the study of liver diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193\u2013213.","DOI":"10.1002\/hep.23584"},{"key":"2022120618373723687_j_med-2022-0526_ref_029","doi-asserted-by":"crossref","unstructured":"Hu CJ, Zhang FC, Li YZ, Zhang X. Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol. 2010;16(29):3616\u201329.","DOI":"10.3748\/wjg.v16.i29.3616"},{"key":"2022120618373723687_j_med-2022-0526_ref_030","doi-asserted-by":"crossref","unstructured":"Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, et al. Antinuclear antibodies giving the \u2018multiple nuclear dots\u2019 or the \u2018rim-like\/membranous\u2019 patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther. 2006;24(11\u201312):1575\u201383.","DOI":"10.1111\/j.1365-2036.2006.03172.x"},{"key":"2022120618373723687_j_med-2022-0526_ref_031","doi-asserted-by":"crossref","unstructured":"Granito A, Muratori P, Quarneti C, Pappas G, Cicola R, Muratori L. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn. 2012;12(1):65\u201374.","DOI":"10.1586\/erm.11.82"},{"key":"2022120618373723687_j_med-2022-0526_ref_032","doi-asserted-by":"crossref","unstructured":"Assassi S, Fritzler MJ, Arnett FC, Norman GL, Shah KR, Gourh P, et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol. 2009;36(10):2250\u20136.","DOI":"10.3899\/jrheum.090340"},{"key":"2022120618373723687_j_med-2022-0526_ref_033","doi-asserted-by":"crossref","unstructured":"Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, et al. Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;26(6):831\u20138.","DOI":"10.1111\/j.1365-2036.2007.03433.x"},{"key":"2022120618373723687_j_med-2022-0526_ref_034","doi-asserted-by":"crossref","unstructured":"Himoto T, Yoneyama H, Kurokohchi K, Inukai M, Masugata H, Goda F, et al. Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases. Can J Gastroenterol. 2012;26(3):125\u20139.","DOI":"10.1155\/2012\/890698"},{"key":"2022120618373723687_j_med-2022-0526_ref_035","doi-asserted-by":"crossref","unstructured":"Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007;45(1):118\u201327.","DOI":"10.1002\/hep.21472"},{"key":"2022120618373723687_j_med-2022-0526_ref_036","doi-asserted-by":"crossref","unstructured":"Saito H, Takahashi A, Abe K, Okai K, Katsushima F, Monoe K, et al. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis. Fukushima J Med Sci. 2012;58(2):107\u201316.","DOI":"10.5387\/fms.58.107"},{"key":"2022120618373723687_j_med-2022-0526_ref_037","doi-asserted-by":"crossref","unstructured":"Tripodi A. Liver Disease and Hemostatic (Dys)function. Semin Thromb Hemost. 2015;41(5):462\u20137.","DOI":"10.1055\/s-0035-1550440"},{"key":"2022120618373723687_j_med-2022-0526_ref_038","doi-asserted-by":"crossref","unstructured":"Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147\u201356.","DOI":"10.1056\/NEJMra1011170"},{"key":"2022120618373723687_j_med-2022-0526_ref_039","doi-asserted-by":"crossref","unstructured":"Xiao Y, Zhou P, Zheng YZ, Zheng C, Liu GW, Liu WX. A nomogram for predicting lateral lymph node metastasis in cases of papillary thyroid micro-carcinoma with suspected lymph node metastasis. Oncologie. 2021;23(2):219\u201328.","DOI":"10.32604\/Oncologie.2021.016480"},{"key":"2022120618373723687_j_med-2022-0526_ref_040","doi-asserted-by":"crossref","unstructured":"Wang Y, Li Y, Wang X, Gacesa R, Zhang J, Zhou L, et al. Predicting liver disease risk using a combination of common clinical markers: a screening model from routine health check-up. Dis Markers. 2020;2020:8460883.","DOI":"10.1155\/2020\/8460883"},{"key":"2022120618373723687_j_med-2022-0526_ref_041","doi-asserted-by":"crossref","unstructured":"Zhang W, De D, Mohammed KA, Munigala S, Chen G, Lai JP, et al. New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome. Hepatol Commun. 2018;2(3):245\u201353.","DOI":"10.1002\/hep4.1148"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2022-0526\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2022-0526\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:47:16Z","timestamp":1670348836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2022-0526\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,28]]},"published-print":{"date-parts":[[2022,3,28]]}},"alternative-id":["10.1515\/med-2022-0526"],"URL":"https:\/\/doi.org\/10.1515\/med-2022-0526","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}